date:Mar 21, 2013
The closing of its deal for California-based Complete Genomics Inc strengthens efforts by BGI-Shenzhen, which operates genome-sequencing centers in China, to grow in the US market for medical and research DNA testing while boosting Chinese hopes of becoming a major industry player, observers say.
BGI-Shenzhen, based in the southern Chinese city in its name, said on Monday that it had completed its $117.6 million tender offer for Complete Genomics, which provides technology used in sequencing th